Albuterol for the treatment of hyperkalemia

Annals of Pharmacotherapy

Volumn 33, Issue 1, 1999, Pages 103-106

  Wong, Shuk Ling ^a,b,c   Maltz, Helene C ^d  

^a ST JOHN'S UNIVERSITY   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c PFIZER INC   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; POTASSIUM; SALBUTAMOL;

CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; HUMAN; HYPERKALEMIA; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; NAUSEA; POTASSIUM BLOOD LEVEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; TREMOR;

EID: 0032956420     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18070     Document Type: Review

References (15)

1. Bourgoignie JJ, Gennari FJ, Rimmer JM. Disturbances in fluid, electrolyte, and acid-base balance. In: Massry SG, Glassock RJ, eds. Massry and Glassock's textbook of nephrology. 3rd ed. Baltimore: Williams and Wilkins, 1995:142740.
2. Allon M. Treatment and prevention of hyperkalemia in end-stage renal disease. Kidney Int 1993;43:1197-209.
3. Murdoch IA, Dos Anjos R, Haycock GB. Treatment of hyperkalaemia with intravenous salbutamol. Arch Dis Child 1990;66:527-8.
4. + ATPase activity in neonatal and adult red blood cells. Biol Neonate 1996;69:140-5.
5. Clausen T, Everts ME. Regulation of Na, K-pump in skeletal muscle. Kidney Int 1989;35:1-13.
6. Allon M, Shanklin N. Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol. Am J Kidney Dis 1996;28:508-14.
7. McClure RJ, Prasad VK, Brocklebank JT. Treatment of hyperkalemia in hemodialysis patients. Kidney Int 1990;38:869-72.
8. Allon M, Copkney C. Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int 1990;38:869-72.
9. Montoliu J, Lens XM, Revert L. Potassium-lowering effect of albuterol for hyperkalemia in renal failure. Ann Intern Med 1987;147:713-7.
10. Montoliu J, Almirall J, Ponz E. Campistol JM, Revert L. Treatment of hyperkalemia in renal failure with salbutamol inhalation. J Intern Med 1990;228:35-7.
11. Price AH, Clissold SP. Salbutamol in the 1980s. A reappraisal of its clinical efficacy. Drugs 1989;38:77-122.
12. Liou HH, Chiang SS, Wu SC, Huang TP, Campese VM, Smogorzewski M. et al. Hypokalemic effect of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study. Am J Kidney Dis 1994;23:266-71.
13. Allon M, Shanklin N. Effect of albuterol treatment on subsequent dialytic potassium removal. Am J Kidney Dis 1995;26:607-13.
14. Allon M, Dunlay R, Copkney C. Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Ann Intern Med 1989;110:426-9.
15. Vestal RE, Wood AJJ, Shand DG. Reduced β-adrenoreceptor sensitivity in the elderly. Clin Pharmacol Ther 1979;26:181-6.